Cargando…
A Dual Therapy of Nanostructured Lipid Carrier Loaded with Teriflunomide—A Dihydro-Orotate Dehydrogenase Inhibitor and an miR-155-Antagomir in Cuprizone-Induced C57BL/6J Mouse
The effective treatment of central nervous system (CNS) disorders such as multiple sclerosis (MS) has been challenging due to the limited ability of therapeutic agents to cross the blood–brain barrier (BBB). In this study, we investigated the potential of nanocarrier systems to deliver miR-155-antag...
Autores principales: | Koduru, Trideva Sastri, Gupta, Vishal N., Veeranna, Balamuralidhara, Seetharaman, Shanmuganathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143733/ https://www.ncbi.nlm.nih.gov/pubmed/37111739 http://dx.doi.org/10.3390/pharmaceutics15041254 |
Ejemplares similares
-
Novel Gels: An Emerging Approach for Delivering of Therapeutic Molecules and Recent Trends
por: Sastri, Trideva K., et al.
Publicado: (2022) -
Behavioral and Neurobiological Changes in C57BL/6 Mouse Exposed to Cuprizone: Effects of Antipsychotics
por: Xu, Haiyun, et al.
Publicado: (2010) -
Relationship of Iron Metabolism and Short-Term Cuprizone Treatment of C57BL/6 Mice
por: Pandur, Edina, et al.
Publicado: (2019) -
Dihydro-orotate dehydrogenase is physically associated with the respiratory complex and its loss leads to mitochondrial dysfunction
por: Fang, JingXian, et al.
Publicado: (2013) -
Protein instability and functional defects caused by mutations of dihydro-orotate dehydrogenase in Miller syndrome patients
por: Fang, JingXian, et al.
Publicado: (2012)